Opiant Pharmaceuticals Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $9.6200
- Today's High:
- $10.3100
- Open Price:
- $9.8300
- 52W Low:
- $7.34
- 52W High:
- $37.71
- Prev. Close:
- $9.9000
- Volume:
- 16352
Company Statistics
- Market Cap.:
- $0.052 billion
- Book Value:
- 5.78
- Revenue TTM:
- $0.039 billion
- Operating Margin TTM:
- -46.5%
- Gross Profit TTM:
- $0.022 billion
- Gross Profit TTM:
- $0.022 billion
- Profit Margin:
- -51.3%
- Return on Assets TTM:
- -20.3%
- Return on Equity TTM:
- -59.9%
Company Profile
Opiant Pharmaceuticals Inc had its IPO on 2016-01-04 under the ticker symbol OPNT.
The company operates in the ENERGY & TRANSPORTATION sector and METAL MINING industry. Opiant Pharmaceuticals Inc has a staff strength of 0 employees.
Stock update
Shares of Opiant Pharmaceuticals Inc opened at $9.83 at the start of the last trading session i.e. 2022-11-02.
The stocks traded within a range of $9.62 - $10.31, and closed at $10.16.
This is a +2.63% increase from the previous day's closing price.
A total volume of 16,352 shares were traded at the close of the day’s session.
In the last one week, shares of Opiant Pharmaceuticals Inc have increased by +1.6%.
Opiant Pharmaceuticals Inc's Key Ratios
Opiant Pharmaceuticals Inc has a market cap of $0.052 billion, indicating a price to book ratio of 1.695 and a price to sales ratio of 1.363.
In the last 12-months Opiant Pharmaceuticals Inc’s revenue was $0.039 billion with a gross profit of $0.022 billion and an EBITDA of $-0.018 billion. The EBITDA ratio measures Opiant Pharmaceuticals Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Opiant Pharmaceuticals Inc’s operating margin was -46.5% while its return on assets stood at -20.3% with a return of equity of -59.9%.
In Q2.3333333333333, Opiant Pharmaceuticals Inc’s quarterly earnings growth was a positive 273.3% while revenue growth was a negative 65.4%.
Opiant Pharmaceuticals Inc’s PE and PEG Ratio
- Forward PE
- 26.74
- Trailing PE
- -
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-1.365 per share while it has a forward price to earnings multiple of 26.74 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Opiant Pharmaceuticals Inc’s profitability.
Opiant Pharmaceuticals Inc stock is trading at a EV to sales ratio of 0.773 and a EV to EBITDA ratio of -1.42. Its price to sales ratio in the trailing 12-months stood at 1.363.
Opiant Pharmaceuticals Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $0.000 billion
- Total Liabilities
- $0.000 billion
- Operating Cash Flow
- $0.000 billion
- Capital Expenditure
- $0.000 billion
- Dividend Payout Ratio
- 0%
Opiant Pharmaceuticals Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.
Opiant Pharmaceuticals Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.
Opiant Pharmaceuticals Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.
In 1970, Opiant Pharmaceuticals Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.
Comparatively, Opiant Pharmaceuticals Inc paid $0 billion in dividends in 1970.
Other key metrics
- Current Trading Price
- $10.16
- 52-Week High
- $37.71
- 52-Week Low
- $7.34
- Analyst Target Price
- $40.33
Opiant Pharmaceuticals Inc stock is currently trading at $10.16 per share. It touched a 52-week high of $37.71 and a 52-week low of $37.71. Analysts tracking the stock have a 12-month average target price of $40.33.
Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Opiant Pharmaceuticals Inc
Similar Industry Stocks (METAL MINING)
Most Active
Top Gainers
Top Losers
About
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops drugs for addiction and drug overdose. The company is headquartered in Santa Monica, California.